Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic
Market Cap
$64.49 Million
₹5.59 Billion INR
Market Cap Rank
#26029 Global
#1380 in India
Share Price
₹319.50
Change (1 day)
+2.50%
52-Week Range
₹310.60 - ₹487.85
All Time High
₹487.85
About

Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more

Kilitch Drugs (India) Limited - Asset Resilience Ratio

Latest as of September 2025: 21.83%

Kilitch Drugs (India) Limited (KILITCH) has an Asset Resilience Ratio of 21.83% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹870.13 Million
Cash + Short-term Investments
Total Assets
₹3.99 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Kilitch Drugs (India) Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Kilitch Drugs (India) Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹330.90 Million 8.3%
Short-term Investments ₹539.23 Million 13.53%
Total Liquid Assets ₹870.13 Million 21.83%

Asset Resilience Insights

  • Good Liquidity Position: Kilitch Drugs (India) Limited maintains a healthy 21.83% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Kilitch Drugs (India) Limited Industry Peers by Asset Resilience Ratio

Compare Kilitch Drugs (India) Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Kilitch Drugs (India) Limited (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Kilitch Drugs (India) Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 16.77% ₹524.66 Million ₹3.13 Billion -8.51pp
2024-03-31 25.28% ₹606.88 Million ₹2.40 Billion +7.30pp
2023-03-31 17.98% ₹394.65 Million ₹2.20 Billion -4.53pp
2022-03-31 22.51% ₹472.34 Million ₹2.10 Billion +4.59pp
2021-03-31 17.92% ₹364.00 Million ₹2.03 Billion -1.56pp
2020-03-31 19.47% ₹278.10 Million ₹1.43 Billion -0.31pp
2019-03-31 19.78% ₹284.16 Million ₹1.44 Billion -7.69pp
2018-03-31 27.47% ₹350.66 Million ₹1.28 Billion +2.37pp
2017-03-31 25.09% ₹283.30 Million ₹1.13 Billion +5.28pp
2016-03-31 19.82% ₹231.21 Million ₹1.17 Billion +0.35pp
2015-03-31 19.47% ₹246.69 Million ₹1.27 Billion -10.88pp
2014-03-31 30.34% ₹391.63 Million ₹1.29 Billion -48.77pp
2013-03-31 79.11% ₹1.08 Billion ₹1.37 Billion +1.34pp
2012-03-31 77.77% ₹1.38 Billion ₹1.77 Billion +77.77pp
2011-03-31 0.00% ₹25.00K ₹1.61 Billion --
pp = percentage points